RxDoctor Payments Data

Elizabeth Billingsley, MD

Dermatology · Hershey, PANPI 1093779340

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $18,047 of the $19,435 with a category attached, or 92.9%. LEO Pharma AS accounts for 89.8% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2020 at $11,622 and has fallen 98.5% since, to $175 in 2025.

$19,435in general payments, 2019–2025

Across 28 payments — averaging $694.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • LEO Pharma AS$17K
  • Galderma Laboratories, L.p.$600
  • Regeneron$378
  • Strata Skin Sciences, Inc.$182
  • Genentech USA, Inc.$176
  • Sun Pharmaceutical Industries Inc.$175
  • plus $478 from 5 others
$28,906in research payments, 2019–2025

Across 15 payments — averaging $1927.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$26K
  • Mayne Pharma Commercial LLC$3K

What the payments were for

  • Consulting fees$18,04793%
  • Food & beverage$1,3887%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,435 in reported general payments places this provider in the 85th percentile of 626 dermatology providers in Pennsylvania.

See all dermatology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$91,071
Medicare patients
146
Services billed
485

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium12$43

Paid to pharmacies, not to this prescriber.

Other dermatology in Hershey

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →